Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-28 @ 1:36 PM
Study NCT ID:
NCT05535569
Status:
COMPLETED
Last Update Posted:
2022-09-10
First Post:
2022-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer
Sponsor:
Yonsei University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-17
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-22
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-07
First Submit QC Date:
None
Study First Post Date:
2022-09-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-09
Last Update Post Date:
2022-09-10
Last Update Post Date Type:
ACTUAL